Market

AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion



AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.


Source link

Related Articles

Back to top button